HER2 negative

Related by string. Her2 negative * Her2 : HER2 positive breast cancer . HER2 positive . HER2 positivity . HER2 positive metastatic breast . HER2 positive tumors . metastatic HER2 positive / Negatives . negatives . NEGATIVE . NEGATIVES . Negative : Rating Watch Negative . Negative Rating Outlook . Negative Outlook reflects . O Negative . Negative Outlook * metastatic HER2 negative *

Related by context. Frequent words. (Click for all words.) 71 HER2 positive 69 hormone receptor positive 69 estrogen receptor negative 68 estrogen receptor positive 66 unresectable 66 distant metastases 64 adjuvant chemotherapy 64 adjuvant therapy 64 metastatic renal cell carcinoma 64 castration resistant prostate cancer 63 gefitinib 63 HRPC 62 PCa 62 metastatic breast cancer 62 metastatic disease 62 metastatic colorectal cancer 62 recurrent ovarian cancer 62 chemoradiation 61 HER2 61 endocrine therapy 61 androgen independent 61 refractory multiple myeloma 61 NSCLC 61 liver metastases 61 trastuzumab 61 docetaxel 61 tumor recurrence 60 FOLFOX 60 brain metastases 60 hormonal therapy 60 hepatocellular carcinoma HCC 60 median PFS 60 hormone refractory prostate cancer 60 B CLL 60 nonresponders 60 temsirolimus 60 metastatic prostate cancer 60 Recurrence Score 59 DLBCL 59 resected 59 HGS ETR1 59 bone metastasis 59 metastatic 59 gemcitabine 59 vinorelbine 59 cisplatin 59 Her2 59 neoplasia 59 letrozole 59 cetuximab 59 vandetanib 59 carcinomas 59 Vectibix 58 prognostic factor 58 advanced NSCLC 58 carboplatin 58 dasatinib 58 adenocarcinomas 58 mitoxantrone 58 BRCA mutations 58 CaP 58 fludarabine 58 nilotinib 58 Metastatic 58 metastatic pancreatic cancer 58 breast tumors 57 anastrozole 57 glioblastoma multiforme GBM 57 evaluable 57 dutasteride 57 bortezomib 57 chronic lymphocytic leukemia CLL 57 sustained virologic response 57 resistant ovarian cancer 57 soft tissue sarcomas 57 evaluable patients 57 estrogen receptor 57 Metastatic Breast Cancer 57 taxane 57 BRCA2 mutations 57 Median survival 56 factor receptor 56 diagnosed multiple myeloma 56 free survival PFS 56 ovarian cancers 56 thromboembolic events 56 VIDAZA 56 hypercalcemia 56 tumor shrinkage 56 adenocarcinoma 56 sunitinib 56 FDG PET 56 paclitaxel 56 hepatocellular carcinoma 56 exemestane 56 chemotherapy regimens 56 monotherapy 56 HER2 positive breast cancer 55 erlotinib 55 Taxotere ® 55 bevacizumab

Back to home page